The limits of innovation: Directly addressing known challenges is necessary to improve the real-world experience of novel medications for opioid use disorder

Acad Emerg Med. 2023 Dec;30(12):1285-1287. doi: 10.1111/acem.14814. Epub 2023 Oct 28.

Authors

Jake R Morgan¹, Sabrina A Assoumou²

Affiliations

¹ Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, Massachusetts, USA.
² Department of Medicine, Boston Medical Center and Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.

PMID: 37793818
PMCID: PMC10841521 (available on 2024-12-01)
DOI: 10.1111/acem.14814

No abstract available

MeSH terms

Analgesics, Opioid / therapeutic use
Humans
Opioid-Related Disorders* / drug therapy

Substances

Analgesics, Opioid

Grants and funding